Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis [Phase 2]
A Phase 2 randomized trial comparing mycophenolate mofetil to azathioprine for maintenance therapy in lupus nephritis has been completed.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Anti-ficolin-3 Autoantibodies in Lupus Nephritis
Clinical trial update on anti-ficolin-3 autoantibodies in lupus nephritis, a manifestation of systemic lupus erythematosus; the study status…
-
CLINICAL_TRIALS research · 2017-02-27Clinical Trial Update: Iguratimod as Treatment for Refractory Lupus Nephritis [NA]
This document notes a clinical trial evaluating iguratimod for refractory lupus nephritis, sponsored by RenJi Hospital; phase and status are…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Anti-ficolin-2 Autoantibodies in Lupus Nephritis
A completed clinical trial investigated anti-ficolin-2 autoantibodies in patients with systemic lupus erythematosus, including lupus nephrit…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis [Phase 2]
A Phase 2 proof-of-concept study of BIIB023 in lupus nephritis was terminated, with results posted in January 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis [Phase 2]
A Phase 2 long-term extension study of BIIB023 in lupus nephritis was terminated, with results posted in January 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) [Phase 1, Phase 2]
This document reports the completion of Phase 1/Phase 2 clinical trials evaluating CTLA4-IgG4m (RG2077) in patients with systemic lupus eryt…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the safety and efficacy of Deoxyspergualin (NKT-01) in patients with lupus nephritis; results have bee…
-
CLINICAL_TRIALS research · 2016-09-14Clinical Trial Update: Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)
Clinical trial update for NCT02313974 (LuFla) on lupus nephritis, reporting lupus flares and histological renal activity at the end of treat…
-
FDA approval · 2016-08-01FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil from Strides Pharma Science Limited under an ANDA.
-
FDA approval · 2016-08-01FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for the generic drug Mycophenolate mofetil from Strides Pharma Science Limited, finalizing changes t…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of CNTO 136 in patients with active lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis [Phase 2, Phase 3]
The update reports on the efficacy and safety of atacicept with mycophenolate mofetil for lupus nephritis. The Phase 2/3 studies were termin…
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for mycophenolate mofetil from Ascend Laboratories, LLC.
-
FDA approval · 2015-11-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application to allow Strides Pharma Science Limited to market a generic mycophenolate mofetil. This approval…
-
FDA approval · 2015-10-30FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mycophenolate mofetil filed by Mylan Pharmaceuticals Inc. The action relates to the approved gen…
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis [Phase 3]
The CHABLIS-SC2 Phase 3 trial of subcutaneous blisibimod for systemic lupus erythematosus (with or without nephritis) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria [Phase 4]
A Phase 4 clinical trial evaluating calcitriol for systemic lupus erythematosus–associated lupus nephritis with persistent proteinuria has b…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis [Phase 4]
Phase 4 clinical trial update evaluating tacrolimus for treatment of systemic lupus erythematosus with membranous nephritis.
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis [NA]
Update on a completed long-term study evaluating multi-target therapy as maintenance treatment for lupus nephritis (NCT01056237).
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy [Phase 3]
A Phase 3 trial comparing two rituximab regimens in lupus nephritis has been terminated.
-
FDA approval · 2015-07-09FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
A completed clinical trial update examining the relationship between periostin levels and renal pathology in chronic kidney disease, includi…
-
FDA approval · 2015-06-01FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Mycophenolate mofetil from Accord Healthcare Inc., updating the approved generic product.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: RING - Rituximab for Lupus Nephritis With Remission as a Goal [Phase 3]
This is an update on a Phase 3 trial evaluating rituximab for lupus nephritis with the goal of achieving remission.